Abstracts Archive - Page 31 of 1683 - ATC Abstracts

2022 American Transplant Congress
Ultrasound Assessing Donor Kidney Quality in Deceased Donor Kidney Transplantation
S. Yun¹, K. Lee¹, S. Park², J. Park¹
¹Surgery, Samsung Medical Center, Seoul, Korea, Republic of, ²Radiology and Center for Imaging Science, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: We evaluated the role of functional kidney volume using donor kidney ultrasound (US) alone or in combination with other donor factors and parameters appropriate…
2022 American Transplant Congress
Deceased Donor Kidney Transplantation from Donors with Acute Kidney Injury: Realities and Costs
S. Iskhagi¹, R. Shahbazov¹, A. Ball¹, S. Loerzel¹, E. Shaban², B. Gallay², R. Hod Dvorai³, J. Leggat², M. Hanlon¹, R. Saidi¹
¹Department of Surgery, Division of Transplantation, SUNY Upstate Medical University, Syracuse, NY, ²Department of Medicine, Division of Nephrology, SUNY Upstate Medical University, Syracuse, NY, ³Department of Pathology and Laboratory Medicine, SUNY Upstate Medical University, Syracuse, NY
*Purpose: The use of kidneys from deceased donors with acute kidney injury (AKI) is one of the options to expand donor pool. Several studied have…
2022 American Transplant Congress
Nebulized Mitochondria Localize to Transplanted Allografts and Improve Outcomes Following Lung Transplantation
D. Nord¹, Z. Tu², L. Langerude¹, A. McQuiston¹, J. Kwon³, S. Nadig⁴, T. Machuca⁵, C. Atkinson¹
¹Pulmonary Medicine, University of Florida, Gainesville, FL, ²University of Florida, Gaineville, FL, ³MUSC College of Medicine, Charleston, SC, ⁴Northwestern University, Charleston, SC, ⁵Department of Surgery, University of Florida, Gainesville, FL
*Purpose: Mitochondrial transplantation therapy is an innovative strategy for the treatment of mitochondrial dysfunction. The approach has shown efficacy in the treatment of cardiac ischemic…
2022 American Transplant Congress
The Impact of the New Allocation System of Kidney Transplantation on a Single Institution
M. Eltemamy, Y. Lin, M. Khalil, S. Agrawal, V. Krishnamurthi, A. Wee
The Cleveland Clinic, Cleveland, OH
*Purpose: The new kidney allocation system went into effect in the middle of March 2021. The consequences of this new system affected transplant centers differently,…
2022 American Transplant Congress
Angiotensin II Type 1 Receptor Antibody in Pediatric Abdominal Organ Transplant: Survey of Clinical Practice in the United States
R. Patnaik, K. Hitchman, N. Mittal, D. Ranch, D. Fritze
University Health Transplant Institute, San Antonio, TX
*Purpose: Some studies correlate Angiotensin II Type 1 Receptor (AT1R) antibodies (Ab) with the development of rejection, vascular complications, and allograft dysfunction in pediatric solid…
2022 American Transplant Congress
Utilizing Online Training Modules and Flowcharts to Maintain Regulatory Compliance with Abo Verification and Organ Check-In Procedures
L. Adamski¹, S. Ceschini², F. K. Butt³
¹Penn State College of Medicine, Hershey, PA, ²Penn State Milton S. Hershey Medical Center, Hershey, PA, ³Penn State Hershey Milton S Medical Center, Hershey, PA
*Purpose: Meeting the regulatory requirements for ABO Verification and solid Organ Check-In procedures is a constant challenge for transplant programs due to continuous turnover in…
2022 American Transplant Congress
Outcomes of Kidney Transplant Recipients with Covid-19 in Singapore Treated with Sotrovimab in the Era of the Delta Variant
M. R. D'Costa¹, H. K. Sran¹, E. Wong¹, Z. Chang², Y. Chua², J. Somani³, L. Lum³, A. Vathsala¹
¹National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore, ²Medicine, National University Hospital, Singapore, Singapore, ³Infectious Diseases, National University Hospital, Singapore, Singapore
*Purpose: Kidney transplant recipients (KTRs) are at higher risk for severe COVID-19 caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Sotrovimab decreases the risk…
2022 American Transplant Congress
Single Center Experience Transplanting Deceased Donor Kidneys with Poor Pump Parameters
M. Garner, B. Sharda, A. Farney, G. Orlando, C. Jay, J. Rogers, A. Reeves-Daniel, A. Mena-Gutierrez, N. Sakhovskaya, R. Stratta
Transplant Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: With the growth of marginal deceased donor (DD) kidney utilization, machine preservation or “pumping” of selected kidneys has become an increasingly important part of…
2022 American Transplant Congress
National Attitudes Towards Early Liver Transplantation for Alcoholic Liver Disease
J. Mitchell¹, K. Nijhar¹, K. Herrick-Reynolds², H. Sung¹, P. Chen¹, D. L. Segev¹, E. King¹, A. Cameron¹
¹Department Of Surgery, Johns Hopkins University, Baltimore, MD, ²Department Of Surgery, Walter Reed National Military Medical Center, Bethesda, MD
*Purpose: Pre-transplant abstinence requirements, notably the 6-month sobriety guideline, limit access to liver transplant for patients with severe alcoholic hepatitis (SAH). This study examines the…
2022 American Transplant Congress
The Impact of Early Graft Infiltrating TCF-1^LowPD-1^HighCD8⁺ T Cells in Delayed Fc Nonbinding Anti-CD3 Antibody Protocol in the Sensitized Mouse Model
T. Ota¹, R. Goto¹, T. Harada¹, Y. Ganchiku¹, M. Zaitsu¹, A. Forgioni¹, N. Kawamura², M. Watanabe², M. Fukai¹, T. Shimamura³, A. Taketomi¹
¹Dept. of Gastroenterological Surgery I, Hokkaido University, Sapporo, Japan, ²Dept. of Transplant Surgery, Hokkaido University, Sapporo, Japan, ³Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Fc nonbinding anti(a)-CD3 antibody has a unique effect that delayed treatment protocol induces a transplant tolerance. Delayed protocol allows early graft infiltrating cells which…